Maggie talked to Dr Peter Gawne about using radioactive nanomedicines for Ovarian Cancer. You don't know what a nanomedicine is? Listen to find out more.

This episode was first published in 2021

John had lots of helpful information to share with Maggie about breaking bad news to patients, the support that is available to patients and he explains about the Nuclear Medicine scans that he has had to check that his bones are clear of cancer.

This podcast series was produced in 2021 by Maggie Cooper from the School of Biomedical Engineering and Imaging Sciences at King's College London.

Maggie spoke with Dr Tim Witney who is pioneering a new radiopharmaceutical which he hopes will be able to predict, very early in a patient's treatment, whether their chemotherapy is going to work.

This podcast series was produced in 2021 by Maggie Cooper from the School of Biomedical Engineering and Imaging Sciences at King's College London.

Maggie spoke to Chris about his experience with gastrointestinal stromal tumour (GIST), how he found out that he had this rare type of cancer and the treatment he has had since.

This podcast series was produced in 2021 by Maggie Cooper from the School of Biomedical Engineering and Imaging Sciences at King's College London.

Maggie spoke to Darlaine about her experience with a less common type of breast cancer called Lobular Breast Cancer. It really is quite different from normal breast cancer and is more difficult to diagnose and manage. Maggie also spoke to Dr George Keeling who is working on developing a new simple method to make a new radiopharmaceutical to detect bone metastases that may result from cancers such as breast cancer or prostate cancer. Here he describes his 'pot noodle' approach to making drugs radioactive.

This podcast series was produced in 2021 by Maggie Cooper from the School of Biomedical Engineering and Imaging Sciences at King's College London.

Did you ever wonder whether different types of radioactivity might be better at treating different types of cancer? In this episode, Maggie talks to Dr Sam Terry who is working on radiation biology and she explains what the radioactivity is doing in the cell and why some types of radioactivity might be better than others. First thought, Maggie spoke to the father of a friend of hers; Vincent was diagnosed with Hodgkin's lymphoma. We talk about his diagnosis and treatment, including his FDG scan and how that went.

This podcast series was produced in 2021 by Maggie Cooper from the School of Biomedical Engineering and Imaging Sciences at King's College London.

Maggie speaks to Maxine who was diagnosed with Ovarian cancer in the middle of the pandemic. We discuss her diagnosis and treatment. Maggie also caught up with Prof James Spicer who heads up a unit carrying our early phase clinical trials in the hospital.

This podcast series was produced in 2021 by Maggie Cooper from the School of Biomedical Engineering and Imaging Sciences at King's College London.

In this episode Maggie talks to Clive about his experience with prostate cancer. She also talks to two scientists in the School of Biomedical Engineering and Imaging Sciences about a new Positron Emission Tomography (PET) Radiopharmaceutical. Prof Gary Cook has been involved in a trial on the new radiopharmaceutical and Dr Jennifer Young was involved in the development of a kit to make it easy to make this new radiopharmaceutical.

This podcast series was produced in 2021 by Maggie Cooper from the School of Biomedical Engineering and Imaging Sciences at King's College London.